We treat one of the largest melanoma populations in New York City and invest in the most advanced technology for digitized, integrated and comprehensive screening.
Melanoma
Melanoma is by far the most serious and virulent form of common skin cancer that develops in the melanocyte cells that produce melanin (pigmentation) in the skin. If the melanoma is invasive and has spread to blood vessels beneath the epidermis, it can spread rapidly to internal organs and the lymphatic system, making early detection critical for successful treatment.
Actinic Keratosis & Squamous Cell Carcinoma
Actinic keratoses (or solar keratoses) develop on the surface of the skin due to extensive UV exposure and damage. They are precancerous lesions but only a number of cases develop into squamous cell carcinoma. These growths are more common among individuals with fair skin, light hair and light eyes.
Squamous cell carcinoma is found in the upper, surface layers of the skin epidermis and it is the most common lethal form of skin cancer. More people die of squamous cell carcinoma than melanoma every year. It can develop anywhere, including the inside of the mouth and the genitals, but is most frequently seen on the scalp, face, ears and the back of the hands. It can develop from actinic keratosis spots, which are scaly precancerous lesions.
Basal Cell Carcinoma
The most common form of skin cancer, basal cell carcinoma stems from the deepest layer of the epidermis by the hair follicle and sweat ducts. This is a slow-growing tumorous cancer that rarely metastasizes and is caused by an overexposure to UVB radiation. Risk factors include fair skin, sun exposure, age (over 50) and exposure to ultraviolet radiation (tanning beds).
Skin Cancer
DERMASENSOR:
AI-ASSISTED LESION ANALYSIS (NON-INVASIVE)
To complement your doctor’s trained eye, we use DermaSensor—an FDA-cleared handheld device that uses optical spectroscopy and artificial intelligence to evaluate suspicious lesions at the point of care. In seconds, it provides an objective risk result (“Investigate Further” or “Monitor”) to aid referral and biopsy decisions. This helps reduce uncertainty and prioritize urgent findings without additional discomfort for you.
How it works: the device takes quick light-based measurements from the skin and its proprietary algorithm analyzes the spectral data to estimate cancer risk (including melanoma, basal cell carcinoma, and squamous cell carcinoma). Your dermatology provider then uses that result, together with the clinical exam, dermoscopy, and medical history, to determine next steps.
DERMENGINE:
TOTAL-BODY DIGITAL PHOTOGRAPHY & TRACKING
We also employ DermEngine, an intelligent dermatology imaging platform designed for documentation, analysis, and secure cloud archiving. With DermEngine’s Total Body Photography (TBP), we capture standardized, high-quality images that make it easier to spot new or changing moles over time. Features like automated mole mapping, evolution tracking, and advanced visual search support more consistent follow-up and clearer conversations about what’s changed since your last visit.
Why this matters for you: high-resolution, standardized photos reduce guesswork and help us focus on areas that truly warrant attention, especially if you have many moles or a personal/family history of skin cancer. DermEngine is accessible across devices and is built with privacy and security safeguards, including HIPAA-aligned controls and secure backups.
WHAT TO EXPECT AT YOUR VISIT:
-
History & Risk Review: We discuss your personal and family risk factors, prior biopsies, and sun exposure.
-
Head-to-Toe Exam: Your dermatologist performs a full-body skin check; dermoscopy may be used for magnified views.
-
Targeted Technology: If a spot looks concerning, we may use DermaSensor for a quick, non-invasive AI-assisted assessment and capture images with DermEngine for documentation and monitoring.
-
Plan & Next Steps: Based on the exam (and, when used, device outputs), we recommend observation, short-term imaging follow-up, or a biopsy.